|
nasdaq:prah
|
6174
|
May 5th, 2024 12:00AM
|
PRA Health Sciences
|
452K
|
5437
|
Open
|
|
May 5th, 2024 12:00AM
|
May 5th, 2024 12:00AM
|
PRA is now an ICON plc company. ICON and PRA have come together as one, creating the world’s most advanced healthcare intelligence and clinical research organisation. We offer the best of both organisations, with a goal to change the way clinical research works, because we know that trials can be done smarter, better and faster.
|
Open
|
Clinical Research, Phase I-IIa, Phase II-III, Safety & Risk Management, Therapeutic Expertise, Biosimilars, Bioanalytical Laboratories, Rare Disease, Oncology, Immunology, Infectious Disease, Neuroscience, Pain, Pediatrics, Vaccines, Data & Techology Solutions, Early Development Services, Laboratory Solutions, Real World Solutions, Clinical Development, Product Registration, Respiratory, Cardio-metabolic, Digital Health, Health Technology, and Digital Therapeutics
|
Open
|
4130 ParkLake Avenue - Suite 400
|
Raleigh
|
North Carolina
|
US
|
27612
|
|
PRA Health Sciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:prah
|
6174
|
May 4th, 2024 12:00AM
|
PRA Health Sciences
|
452K
|
5437
|
Open
|
|
May 3rd, 2024 11:34PM
|
May 4th, 2024 07:14PM
|
PRA is now an ICON plc company. ICON and PRA have come together as one, creating the world’s most advanced healthcare intelligence and clinical research organisation. We offer the best of both organisations, with a goal to change the way clinical research works, because we know that trials can be done smarter, better and faster.
|
Open
|
Clinical Research, Phase I-IIa, Phase II-III, Safety & Risk Management, Therapeutic Expertise, Biosimilars, Bioanalytical Laboratories, Rare Disease, Oncology, Immunology, Infectious Disease, Neuroscience, Pain, Pediatrics, Vaccines, Data & Techology Solutions, Early Development Services, Laboratory Solutions, Real World Solutions, Clinical Development, Product Registration, Respiratory, Cardio-metabolic, Digital Health, Health Technology, and Digital Therapeutics
|
Open
|
4130 ParkLake Avenue - Suite 400
|
Raleigh
|
North Carolina
|
US
|
27612
|
|
PRA Health Sciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:prah
|
6174
|
May 3rd, 2024 12:00AM
|
PRA Health Sciences
|
452K
|
5446
|
Open
|
|
May 2nd, 2024 11:31PM
|
May 3rd, 2024 03:00PM
|
PRA is now an ICON plc company. ICON and PRA have come together as one, creating the world’s most advanced healthcare intelligence and clinical research organisation. We offer the best of both organisations, with a goal to change the way clinical research works, because we know that trials can be done smarter, better and faster.
|
Open
|
Clinical Research, Phase I-IIa, Phase II-III, Safety & Risk Management, Therapeutic Expertise, Biosimilars, Bioanalytical Laboratories, Rare Disease, Oncology, Immunology, Infectious Disease, Neuroscience, Pain, Pediatrics, Vaccines, Data & Techology Solutions, Early Development Services, Laboratory Solutions, Real World Solutions, Clinical Development, Product Registration, Respiratory, Cardio-metabolic, Digital Health, Health Technology, and Digital Therapeutics
|
Open
|
4130 ParkLake Avenue - Suite 400
|
Raleigh
|
North Carolina
|
US
|
27612
|
|
PRA Health Sciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:prah
|
6174
|
May 2nd, 2024 12:00AM
|
PRA Health Sciences
|
452K
|
5447
|
Open
|
|
May 1st, 2024 11:39PM
|
May 2nd, 2024 10:39AM
|
PRA is now an ICON plc company. ICON and PRA have come together as one, creating the world’s most advanced healthcare intelligence and clinical research organisation. We offer the best of both organisations, with a goal to change the way clinical research works, because we know that trials can be done smarter, better and faster.
|
Open
|
Clinical Research, Phase I-IIa, Phase II-III, Safety & Risk Management, Therapeutic Expertise, Biosimilars, Bioanalytical Laboratories, Rare Disease, Oncology, Immunology, Infectious Disease, Neuroscience, Pain, Pediatrics, Vaccines, Data & Techology Solutions, Early Development Services, Laboratory Solutions, Real World Solutions, Clinical Development, Product Registration, Respiratory, Cardio-metabolic, Digital Health, Health Technology, and Digital Therapeutics
|
Open
|
4130 ParkLake Avenue - Suite 400
|
Raleigh
|
North Carolina
|
US
|
27612
|
|
PRA Health Sciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:prah
|
6174
|
May 1st, 2024 12:00AM
|
PRA Health Sciences
|
452K
|
5451
|
Open
|
|
May 1st, 2024 01:29AM
|
May 1st, 2024 10:03AM
|
PRA is now an ICON plc company. ICON and PRA have come together as one, creating the world’s most advanced healthcare intelligence and clinical research organisation. We offer the best of both organisations, with a goal to change the way clinical research works, because we know that trials can be done smarter, better and faster.
|
Open
|
Clinical Research, Phase I-IIa, Phase II-III, Safety & Risk Management, Therapeutic Expertise, Biosimilars, Bioanalytical Laboratories, Rare Disease, Oncology, Immunology, Infectious Disease, Neuroscience, Pain, Pediatrics, Vaccines, Data & Techology Solutions, Early Development Services, Laboratory Solutions, Real World Solutions, Clinical Development, Product Registration, Respiratory, Cardio-metabolic, Digital Health, Health Technology, and Digital Therapeutics
|
Open
|
4130 ParkLake Avenue - Suite 400
|
Raleigh
|
North Carolina
|
US
|
27612
|
|
PRA Health Sciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:prah
|
6174
|
Apr 30th, 2024 12:00AM
|
PRA Health Sciences
|
452K
|
5451
|
Open
|
|
Apr 29th, 2024 11:58PM
|
Apr 30th, 2024 08:56AM
|
PRA is now an ICON plc company. ICON and PRA have come together as one, creating the world’s most advanced healthcare intelligence and clinical research organisation. We offer the best of both organisations, with a goal to change the way clinical research works, because we know that trials can be done smarter, better and faster.
|
Open
|
Clinical Research, Phase I-IIa, Phase II-III, Safety & Risk Management, Therapeutic Expertise, Biosimilars, Bioanalytical Laboratories, Rare Disease, Oncology, Immunology, Infectious Disease, Neuroscience, Pain, Pediatrics, Vaccines, Data & Techology Solutions, Early Development Services, Laboratory Solutions, Real World Solutions, Clinical Development, Product Registration, Respiratory, Cardio-metabolic, Digital Health, Health Technology, and Digital Therapeutics
|
Open
|
4130 ParkLake Avenue - Suite 400
|
Raleigh
|
North Carolina
|
US
|
27612
|
|
PRA Health Sciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:prah
|
6174
|
Apr 29th, 2024 12:00AM
|
PRA Health Sciences
|
452K
|
5451
|
Open
|
|
Apr 29th, 2024 02:35AM
|
Apr 29th, 2024 10:04AM
|
PRA is now an ICON plc company. ICON and PRA have come together as one, creating the world’s most advanced healthcare intelligence and clinical research organisation. We offer the best of both organisations, with a goal to change the way clinical research works, because we know that trials can be done smarter, better and faster.
|
Open
|
Clinical Research, Phase I-IIa, Phase II-III, Safety & Risk Management, Therapeutic Expertise, Biosimilars, Bioanalytical Laboratories, Rare Disease, Oncology, Immunology, Infectious Disease, Neuroscience, Pain, Pediatrics, Vaccines, Data & Techology Solutions, Early Development Services, Laboratory Solutions, Real World Solutions, Clinical Development, Product Registration, Respiratory, Cardio-metabolic, Digital Health, Health Technology, and Digital Therapeutics
|
Open
|
4130 ParkLake Avenue - Suite 400
|
Raleigh
|
North Carolina
|
US
|
27612
|
|
PRA Health Sciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:prah
|
6174
|
Apr 28th, 2024 12:00AM
|
PRA Health Sciences
|
452K
|
5448
|
Open
|
|
Apr 27th, 2024 11:52PM
|
Apr 27th, 2024 11:52PM
|
PRA is now an ICON plc company. ICON and PRA have come together as one, creating the world’s most advanced healthcare intelligence and clinical research organisation. We offer the best of both organisations, with a goal to change the way clinical research works, because we know that trials can be done smarter, better and faster.
|
Open
|
Clinical Research, Phase I-IIa, Phase II-III, Safety & Risk Management, Therapeutic Expertise, Biosimilars, Bioanalytical Laboratories, Rare Disease, Oncology, Immunology, Infectious Disease, Neuroscience, Pain, Pediatrics, Vaccines, Data & Techology Solutions, Early Development Services, Laboratory Solutions, Real World Solutions, Clinical Development, Product Registration, Respiratory, Cardio-metabolic, Digital Health, Health Technology, and Digital Therapeutics
|
Open
|
4130 ParkLake Avenue - Suite 400
|
Raleigh
|
North Carolina
|
US
|
27612
|
|
PRA Health Sciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:prah
|
6174
|
Apr 27th, 2024 12:00AM
|
PRA Health Sciences
|
452K
|
5450
|
Open
|
|
Apr 26th, 2024 11:31PM
|
Apr 26th, 2024 11:31PM
|
PRA is now an ICON plc company. ICON and PRA have come together as one, creating the world’s most advanced healthcare intelligence and clinical research organisation. We offer the best of both organisations, with a goal to change the way clinical research works, because we know that trials can be done smarter, better and faster.
|
Open
|
Clinical Research, Phase I-IIa, Phase II-III, Safety & Risk Management, Therapeutic Expertise, Biosimilars, Bioanalytical Laboratories, Rare Disease, Oncology, Immunology, Infectious Disease, Neuroscience, Pain, Pediatrics, Vaccines, Data & Techology Solutions, Early Development Services, Laboratory Solutions, Real World Solutions, Clinical Development, Product Registration, Respiratory, Cardio-metabolic, Digital Health, Health Technology, and Digital Therapeutics
|
Open
|
4130 ParkLake Avenue - Suite 400
|
Raleigh
|
North Carolina
|
US
|
27612
|
|
PRA Health Sciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:prah
|
6174
|
Apr 26th, 2024 12:00AM
|
PRA Health Sciences
|
452K
|
5450
|
Open
|
|
Apr 25th, 2024 11:39PM
|
Apr 26th, 2024 08:59AM
|
PRA is now an ICON plc company. ICON and PRA have come together as one, creating the world’s most advanced healthcare intelligence and clinical research organisation. We offer the best of both organisations, with a goal to change the way clinical research works, because we know that trials can be done smarter, better and faster.
|
Open
|
Clinical Research, Phase I-IIa, Phase II-III, Safety & Risk Management, Therapeutic Expertise, Biosimilars, Bioanalytical Laboratories, Rare Disease, Oncology, Immunology, Infectious Disease, Neuroscience, Pain, Pediatrics, Vaccines, Data & Techology Solutions, Early Development Services, Laboratory Solutions, Real World Solutions, Clinical Development, Product Registration, Respiratory, Cardio-metabolic, Digital Health, Health Technology, and Digital Therapeutics
|
Open
|
4130 ParkLake Avenue - Suite 400
|
Raleigh
|
North Carolina
|
US
|
27612
|
|
PRA Health Sciences
|
Health Care
|
Pharmaceuticals & Biotechnology
|